Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
about
Cj1411c encodes for a cytochrome P450 involved in Campylobacter jejuni 81-176 pathogenicityCampylobacter surface-layers (S-layers) and immune evasion.Campylobacter fetus sap inversion occurs in the absence of RecA function.Clinical aspects of Campylobacter jejuni infections in adults.In vitro evaluation of the role of antibodies against Helicobacter pylori in inhibiting adherence of the organism to gastric cells.Campylobacter fetus surface layer proteins are transported by a type I secretion system.Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis.Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuniIdentification of immunogenic and virulence-associated Campylobacter jejuni proteins.Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitroExtraintestinal Campylobacter infections.Pathogenesis of Campylobacter fetus infections. Role of surface array proteins in virulence in a mouse modelLipooligosaccharide locus class of Campylobacter jejuni: sialylation is not needed for invasive infection.Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobialsSurface array proteins of Campylobacter fetus block lectin-mediated binding to type A lipopolysaccharide.Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.Plasma cytokine response in mice with bacterial infection.Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.Nested DNA inversion as a paradigm of programmed gene rearrangement.Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus.Reattachment of surface array proteins to Campylobacter fetus cells.A Phase-Variable Surface Layer from the Gut Symbiont Bacteroides thetaiotaomicronHuman disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States.Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse.Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli.Campylobacter jejuni arthritis in secondary amyloidosis.Detection of pathogenic Campylobacter species in blood culture systemsHost-pathogen interactions in Campylobacter infections: the host perspective.Virulence of Campylobacter jejuni for chicken embryos is associated with decreased bloodstream clearance and resistance to phagocytosis.Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation.Immune response of athymic and euthymic germfree mice to Campylobacter spp.Two-dimensional gel electrophoresis and immunoblotting of Campylobacter outer membrane proteins.Lipopolysaccharide structures of Campylobacter fetus are related to heat-stable serogroups.Pathophysiology of Campylobacter enteritis.Campylobacter jejuni strains from patients with Guillain-Barré syndromeCampylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression.Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDSBacteraemia caused by Campylobacter sppVirulence characteristics of five new Campylobacter jejuni chicken isolatesImmunity to Campylobacter: its role in risk assessment and epidemiology.
P2860
Q28533834-28452DF1-D983-4AE6-8071-69E8B0D03F0AQ30351039-7D11F073-E4AE-4E78-BE67-F2FE547D86F3Q33591781-84F35665-5F47-4F1D-81D7-71CB98E7A0CDQ33607865-7ED78BB7-6995-45ED-BDDA-0015D9052E83Q33618181-27C20607-3238-493B-9EF8-A8F96D0BD8C8Q33743972-2BE843FE-3774-4E89-8AE3-6D69C1F0559DQ33769180-EF31E646-0EC7-45F4-AC5E-4D3C2D89EFE8Q34005157-34611B87-4CD5-4B11-AE0B-E624DB92A9C2Q34095868-0B90F34D-92A0-43CE-A600-D4B615112A11Q34116680-30A37C7B-F155-40F8-A0BA-39205B9C1E98Q34193499-5863BA32-9312-400C-BDDE-90301B3E3C60Q34247203-7A6C74B6-CB79-4190-80BF-DA7AB8520723Q34531642-393B323E-6317-42BB-9870-945A368F5446Q34775371-4900D2A3-A5C9-422E-9E09-1655498F849EQ35103052-0B48D971-498B-4521-8171-CA530B7AEE0CQ35587941-67DF8B70-986D-46F1-ADC3-8625BCEBCFE6Q35609694-8936B7B3-CD9A-4C64-AC75-E782D285E505Q35904500-703D6AE9-9D39-4CA3-9669-FE97FDDCB53FQ35967296-D044D08D-9C8B-42CE-8FB5-789F1C3CCE63Q36103972-3793BC85-76DE-4544-ACA7-314C36DB76C1Q36118286-35166877-6FDB-448B-9B4B-4951958F13EEQ36177545-5293B6BC-D344-45AA-8E2A-2F5F18F85D11Q36416983-78240A80-9C0C-4909-A9AA-6E6F1A5AC9BCQ36473180-16D94283-5100-4F05-B16A-CCDABBC20FBEQ36546036-BF04E065-1C2B-4306-905E-097D21E2CFB7Q36708586-F5FCE9E3-EFCB-4BF8-8935-B66DCEC0DA29Q36771697-70B45525-01B5-40CC-BDBF-FDC01E7CB06CQ36803887-2F4F34B3-3375-491E-8673-454F1D33511BQ36962322-A6B0630B-0D1D-40DC-A557-4F8CEF4CCEA2Q36992488-355CDCF1-5B36-4659-A78C-27C556CD9046Q37012859-804FA48C-AF9F-495F-AEE5-0BFF4C2591BAQ37020586-168D4D92-E8D5-4BAF-BCA1-573FFC294CE3Q37030674-C98C19F1-DAC7-4627-A2FF-4F6E2F737D65Q37062418-1E77BE4F-2F4A-4D3C-B2FC-EE09B64AF7B2Q37092333-E19FF0E2-631B-4714-A63B-D685F348EF67Q37191384-F0E6A18C-90D9-44CD-914E-5F9CC6FF62E2Q37246030-C81415FB-0281-49D9-96C1-792174309F55Q37246637-FC8957B3-AD89-40FC-96AD-53F7BF25ED89Q37400916-9D79FF11-63F7-49AC-A200-44CA6B4FD0C3Q37514240-055E72B2-61A0-4A1D-896A-3865D69E0BDD
P2860
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@en
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@nl
type
label
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@en
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@nl
prefLabel
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@en
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@nl
P356
P1476
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
@en
P2093
P304
P356
10.1093/INFDIS/151.2.227
P407
P577
1985-02-01T00:00:00Z